Chinese Society for Immunology

Local Meetings

• 

  Summary of the 18th National Conference on Tumor Biotherapy & National Conference on Tumor Cell Therapy and Immunotherapy

  2025-05-15

  From April 25 to 27, 2025, the Chinese Society for Immunology (CSI) hosted the 18th National Conference on Tumor Biotherapy & the National Conference on Tumor Cell Therapy and Immunotherapy in Xi'an, Shaanxi Province. The conference was co-organized by the CSI Tumor Immunology and Biotherapy Committee, the Tumor Biotherapy Committee of the Chinese Anti-Cancer Association, and the Chinese Journal of Tumor Biotherapy. Under the strategic guidance of honorary chairs Academicians Xuetao Cao, Zhigang Tian, and Yuzhang Wu, and with the joint efforts of conference chairs Professors Bo Huang and Yi Zhang, the event saw enhanced influence, attracting 563 registered representatives, plus invited speakers and 15 exhibitors, totaling nearly 700 attendees.On the afternoon of April 25, the conference featured four pre-conference forums, focusing on CAR-T therapy, antibody-drug conjugates (ADC), oncolytic viruses, and next-generation tumor immunotherapy. 12 experts engaged in heated academic discussions with attendees. These experts and their presentation topics are as follows: • Associate Professor Haopeng Wang (ShanghaiTech University): Mechanisms of Immune Receptor Signaling and Clinical Applications • Researcher Zonghai Li, (CARsgen Therapeutics Holdings Limited): Strategies to Address Key Challenges in CAR-T Cell Drug Development • Professor Yongxian Hu (First Affiliated Hospital of Zhejiang University School of Medicine): Applications of Cellular Immunotherapy in Hematologic Malignancies • Professor Tianlei Ying (Fudan University): Development of Novel Antibody-Drug Conjugates Based on Fully Human Nanobodies • Dr. Zhican Qu, (NAAN Bio): ADC & RDC—Development and Applications of Antibody-Drug Conjugates and Radiopharmaceuticals • Professor Lin Shen (Peking University Cancer Hospital): Clinical Practices and Insights in Gastrointestinal Tumor Cell Therapy • Professor Yaohe Wang (Queen Mary University of London): Advances and Challenges in Oncolytic Virotherapy: From Preclinical Models to Clinical Translation • Dr. Yang Wang (Binhe Biotech Co., Ltd.): Oncolytic Viruses: From Basic Research to Clinical Applications • Professor Yongxiang Zhao (Guangxi Medical University): Leveraging Strengths and Targeting Tumors with Toxicity-Based Strategies • Associate Researcher Jiadi Lü (Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences): Using Biomechanical Signals to Achieve Ex Vivo Expansion of Potent CAR-T Cells • Professor Guideng Li (Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences): Enhancing T Cell Tumor Immunotherapy Through Metabolic Targeting • Researcher Lairuan Huang (Renji Hospital, Shanghai Jiao Tong University School of Medicine): Neutrophils: The Power of ManyThe conference opening took place on April 26, hosted by CSI Secretary-General Prof. Limin Zheng. Honorary CSI Chairman, Academician Xuetao Cao, and CSI President, Prof. Bo Huang, delivered remarks highlighting China's tumor immunology advancements, clinical applications, and innovative technologies. They emphasized the importance of strengthening academic exchange, supporting national strategies, and fostering collaboration among researchers.After the opening ceremony, the conference officially transitioned into an exciting series of academic presentations. The first session featured invited keynote speeches led by the honorary conference chair, with 5 distinguished academicians presenting their latest research: • Academician Xuetao Cao (Chinese Academy of Engineering, Chinese Academy of Medical Sciences): New Targets and Therapeutic Strategies in Innate Immunity and Immunotherapy • Academician Yuzhang Wu (Chinese Academy of Engineering, Army Medical University): From Understanding to Innovation—Decoding, Evaluating, Intervening, and Reconstructing Human Immunity • Academician Zhinan Chen (Chinese Academy of Engineering, Air Force Medical University): Pathogen Receptors and Host Immune Homeostasis • Academician Erwei Song (Chinese Academy of Sciences, Sun Yat-sen Memorial Hospital, Sun Yat-sen University): Deployment of Effector Immune Cells—The Hot and Cold Issues of Tumor Immunity • Academician Zemin Zhang (Chinese Academy of Sciences, Peking University): Deciphering the Tumor Microenvironment through Data Integration Following these presentations, 3 international experts from renowned research institutions shared their latest findings: • Prof. Benoit Van den Eynde (Ludwig Institute for Cancer Research): Adrenergic Control of Anti-Tumor Immunity • Prof. Qi-Jing Li (Institute of Molecular and Cell Biology, Singapore): Deciphering Tumor Evasion: Insights from the Local Microenvironment and Systemic Interactions • Prof. Enrico Lugli (Humanitas Research Hospital, Italy): Immunosuppression in the Tumor Microenvironment These presentations provided valuable insights into tumor immunology, immune regulation, and clinical advancements, enriching the discussions among participants.On the afternoon of April 26, the conference featured invited keynote speeches by 7 senior experts, led by the President of the CSI. Their presentations covered advanced topics in tumor immunology and therapy: • Prof. Bo Huang (Chinese Academy of Medical Sciences & Peking Union Medical College): Power of Softness in Mechano-Onco-Immunology • Prof. Yangxin Fu (Tsinghua University): Orchestrating Intratumoral DC-T Cell Immunity for Local and Distal Tumor Control • Prof. Ruihua Xu (Sun Yat-sen University Cancer Center): Innovations in Gastrointestinal Tumor Immunotherapy • Researcher Chenqi Xu (Chinese Academy of Sciences, Center for Excellence in Molecular Cell Science): Rational Design of CAR Molecules Based on Electrostatic Regulation • Prof. Yiwei Chu (Fudan University): Antitumor Effects of CAR-TFoxp3 Cells • Researcher Feifei Luo (Fudan University, Huashan Hospital): Regulation of STING Output Rebalancing Mechanisms and Drug Resistance Reversal Strategies • Prof. Limin Zheng (Sun Yat-sen University): Myeloid Immune Cells and Tumor Tissue Microenvironment ShapingOn the morning of April 27, the joint conference chairs led an academic exchange session featuring 9 mid-career and young experts, who presented innovative research in tumor immunotherapy and cellular metabolism: • Prof. Yi Zhang (First Affiliated Hospital of Zhengzhou University): Key Clinical Issues and Solutions in Tumor Cell Immunotherapy • Prof. Lilin Ye (Army Medical University): CD8+ T Cell Memory and Cancer Immunotherapy • Prof. Bo Zhu (Second Affiliated Hospital of Army Medical University): Heterogeneity of Immune Response in Metastatic Organs and Strategies to Overcome It • Researcher Qiang Zou (Shanghai Jiao Tong University): Tumor Immunity and Metabolism • Researcher Guoliang Cui (University of Science and Technology of China): Lipid Metabolism in the Tumor Microenvironment and Immune Exhaustion • Prof. Hongxia Wang (Fudan University Cancer Hospital): Targeting Tumor Stem Cells and Immune Evasion: From Basic Research to Clinical Applications • Prof. Jin Hou (Naval Medical University): Exploring Novel Chemo-Immunotherapy Combination Strategies for Tumors • Prof. Xiaohu Zheng (University of Science and Technology of China): Metabolic Mechanisms and Interventions for Dysfunctional NK Cells in the Tumor Microenvironment • Prof. Ke Tang (Huazhong University of Science and Technology): Novel Antitumor Immunotherapy Strategies Based on Tumor Extracellular Vesicles These sessions provided critical insights into tumor immunotherapy advancements, clinical applications, and emerging therapeutic approaches, fostering in-depth discussions among attendees.After a total of 36 engaging academic presentations, the conference hosted a Corporate Forum on the afternoon of April 27 as a strategic initiative to promote innovation and industry development. The forum invited biopharmaceutical companies specializing in tumor immunotherapy, investors, and principal investigators (PIs) for in-depth discussions. Participants openly exchanged insights on key challenges in business development, investment concerns, the transition from basic research to clinical applications, market demands, and new drug innovation. The discussions covered various aspects of the industry, fostering constructive dialogue among experts. Attendees recognized the conference’s role in facilitating academic exchange and improving communication across sectors, emphasizing the importance of the society’s position as a bridge between the scientific community and government. They expressed hope that the society could further address regulatory, financial, and policy challenges in the immunotherapy industry, identify common industry issues, and propose solutions—ultimately contributing to sustainable industry growth and advancing public health.

  Read More
• 

  Summary of the 3rd CSI Advanced Course of Cancer Immunotherapy

  2022-08-30

  The 3rd CSI Advanced Course of Cancer Immunotherapy was successfully held during August 5-7 in Kunming. 15 top immunologists were invited to give lectures. The hybrid course attracted over 200 trainees.In the opening speech given by CSI President, Prof. Yuzhang Wu, it was emphasized that CSI has been striving to promote the application of recent findings in immunotherapy to the clinical practices. Besides, it is also an important job for CSI to design and provide different training courses to fulfill current needs. On behalf of CSI, Prof. Wu thanked lecturers and sponsors for their great supports to the meeting.The followings are the lecturers and their topics: Prof. Xuetao Cao, New targets and ways of research and application of caner immunotherapy Prof. Yuzhang Wu, Advances and challenges in immunotherapy Prof. Bo Huang, Mechanism of how T cell recognizes tumor antibodies of self-origin Prof. Yan Shi, Trigger and effect of innate immunity Prof. Wanli Liu, A germline variant of human IgG1 represses colorectal tumorigenesis and progression by shaping the tumor microenvironment Prof. Bo Huang, Occurrence and regression of inflammation Prof. Shuyang Yu, Research of SR protein regulation of development, differentiation and function of thymic T cells Prof. Yangxin Fu, The history of cancer immunotherapy and new trends Prof. Youhai Chen, New immune checkpoints and cancer immune therapy Prof. Haopeng Wang, Transportation mechanism and clinical application of CAR Prof. Yi Zhang, Trends of cancer immunotherapy research: Inspiration from clinical practices Prof. Xiubao Ren, Toxic and side effects in cancer immunotherapy Prof. Dawang Zhou, Regulatory functions of Hippo signal pathway in cancer immunity Prof. Yiwei Chu, Regulatory B Lymphocytes in Diseases Prof. Ping Gao, Regulatory mechanisms and targeted therapy of tumor metabolic reprogramming Prof. Liufu Deng, T cell stemness programs and new strategies of cancel immunotherapyProf. Bo Huang, the Secretary General of CSI, gave the closing speech. He summarized each lecture and asked trainees for their precious suggestions to the 4th advanced course programme, which will be held next year.

  Read More
• 

  Summary of Frontier Forum on Immune Metabolism

  2022-05-19

  Being aware of the importance of cross-regulation of immunity and metabolism for immune system development and function and with the aim to promote basic and translational research of Immunology in China, especially in the field of immune metabolism, the "Frontier Forum on Immune Metabolism (Online)" was held on May 15, 2022. Initiated by Professors Xuetao Cao and Yuzhang Wu, the conference was jointly sponsored by the Chinese Society of Immunology and the National Key Laboratory of Medical Immunology.Well-known experts in immune metabolism research and young immunologists who have made original achievements in recent years were invited to give speech. They are: Professor Bo Huang from the Chinese Academy of Medical Sciences/Peking Union Medical College, Professor Rongbin Zhou from University of Science and Technology of China, Professor Di Wang from Zhejiang University School of Medicine, and Professor Peng Jiang from School of Life Sciences of Tsinghua University, Professor Yifu Qiu from the College of Future Technology of Peking University, Professor Zeping Hu from the School of Pharmaceutical Sciences of Tsinghua University, Professor Hongbo Hu from West China Hospital of Sichuan University, and Professor Qiang Zou from Shanghai Jiao Tong University School of Medicine. During the meeting impressive reports were made, the latest progress in immune metabolism was discussed, and multi-aspect academic exchanges and cooperation were promoted. The topics covered the advances and progresses in the field of immune metabolism, including metabolic remodeling and molecular mechanism of inflammation, infection and tumor, metabolic regulation of immune cell development and function, metabolic dysregulations of immune related diseases, application of metabolomics technology in Immunology research and other frontier fields.This meeting had attracted great interests from Immunology researchers and students. The total number of hits of the live broadcast of the conference reached 25,012, and the number of participants was 17,072. Warm interactive discussions were made between speakers and audience, and the conference achieved the aim to strengthen the academic community and activate exchanges in the field.Chairmen of the meeting: Juan Liu（National Key Laboratory of Medical Immunology, Institute of Immunology, Second Military Medical University） Bin Li（Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine） Zhongjun Dong（School of Medicine and Institute for Immunology, Tsinghua University）

  Read More
• 

  Summary of the 2nd CSI Advanced Course of Cancer Immunotherapy

  2021-07-05

  The 2nd CSI Advanced Course of Cancer Immunotherapy was successfully held during June 18-20 in Shanghai. 23 top immunologists were invited to give lectures on basic scientific theories and recent achievements of cancer immunotherapy. The exciting program attracted nearly 200 trainees to the meeting.The following are the lecturers and their topics:Prof. Xuetao Cao, Research and application of Caner immunotherapy Prof. Zhigang Tian, Synthetic immunology and next generation immunotherapy Prof. Yuzhang Wu, Advances and challenges in immunotherapy Prof. Bo Huang, Occurrence and regression of inflammation Prof. Angang Yang, Trastuzumab treatment resistance in breast cancer and immune editing Prof. Ling Lv, Regulation of Immune Tolerance by FOXP3 Prof. Binghe Xu, New advances in medical oncology therapy Prof. Yan Shi, Trigger and effect of innate immunity Prof. Bing Sun, The function of Major Histocompatibility Complex (MHC) in T cell activation and anti-tumor immunotherapy Prof. Chen Dong, Immune checkpoints and T cell depletion Prof. Jie Liu, New strategies for tumor diagnosis and treatment based on immune homeostasis Prof. Yu Zhang, Manipulating thymus T cell development enhances anti-tumor immunity Prof. Limin Zheng, Source, regulation and significance of tumor tissue myeloid-derived suppressor cells Prof. Qingqing Wang, The key role of the tumor microenvironment: myeloid cells Prof. Yi Zhang, Basic and clinical of tumor vaccine Prof. Bo Zhu, Immune checkpoint inhibitors resistance mechanism and overcoming strategies Prof. Weidong Han, Enhancement strategies of CAR-T functionality and resistance in B cell malignancies Prof. Yiwei Chu, The optimal design of CAR-T and its anti-tumor efficacy and mechanism Prof. Zhengfan Jiang, Research on cGAS-STING pathway and tumor manganese immunotherapy Prof. Shengdian Wang, The problems faced by PD-1 blockers in tumor treatment and the development of new treatment strategies Prof. Chenqi Xu, T cell receptor signaling and applications Prof. Xin Lin, Developing TCR-based CAR-T cell approach for cancer immunotherapy Prof. Yuting Ma, Immune perception and immune regulation of stressThis serial course is aimed to promote translational research in tumor biology and tumor immunology, to enhance clinical application of the treatment of some cancers’ immunotherapy. We are happy to see active reactions from our trainees and the 3rd course has been put on the agenda.

  Read More
• 

  Summary of the 16th National Cancer Immunotherapy Meeting & the 1st CSI Advanced Course of Cancer Immunotherapy

  2020-11-13

  The 16th National Cancer Immunotherapy Meeting & the 1st CSI Advanced Course of Cancer Immunotherapy was held during November 6 to 9, 2020 in Beijing. As a biennial meeting organized by the CSI Committee for Tumor Immunology & Biotherapy, the National Cancer Immunotherapy Meeting has been held 16 times since 1989. As for the CSI Advanced Course of Cancer Immunotherapy, it is a new training course developed by CSI. For decades CSI has been working on and providing different training courses for different groups, including Recent Advances Workshop, Young Immunologist Forum, National Doctoral Forum and Summer School. This year, with the aim to attract more clinicians to CSI educational activities and to enhance the transformation of immunotherapy from basis to practice, CSI decided to start a new training course: CSI Advanced Course of Cancer Immunotherapy. During the opening ceremony a special guest was invited to give a speech for the trainees – Prof. Denian Ba, who was the President of the 2nd and 3rd CSI council. He talked about the hard work of the first generations of immunotherapy researchers, and he showed his belief in the young researchers and clinicians to make cancer a less horrible disease. Everyone was encouraged by his warm words and touched by his stories.Altogether 21 lectures were given by invited prestigious speakers, many of which are CSI council members. These lecturers are: Prof. Xuetao Cao (Past President), Prof. Zhigang Tian (Chief Supervisor), Prof. Yuzhang Wu (President), Prof. Wei He (Past Secretary General), Prof. Dalong Ma (Past Vice President), Prof. Bing Sun (Vice President), Prof. Zhi Yao (Vice President), Prof. Li Wu (Vice President), Prof. Yiwei Chu (Vice President), Prof. Bo Huang (Vice President & Secretary General), Prof. Yu Zhang, Prof. Xiaofeng Qin, Prof. Zhengfan Jiang, Prof. Weidong Han, Prof. Limin Zheng, Prof. Yi Zhang, Prof. Shengdian Wang and Prof. Bo Zhu. Their topics covered history of the field, explanation of the important issues in basic immunology, trends and challenges of immunotherapy. Questions were asked and answered in the end of each lecture, and opinions were exchanged during the tea breaks.It was a big success for the 1st CSI Advanced Course of Cancer Immunotherapy. CSI will put more effort into the program design to make it an attractive serial educational activity.

  Read More
• 

  6th Cross Straight Immunology Conference was held in Taipei

  2017-03-24

  The 6th Cross Straight Immunology Conference, organized by Graduate Institute of Immunology, Taiwan University, has been held in Taipei, March 18-19th, 2017. The Opening Ceremony was presided over by Prof. Bingning Xu from Taiwan University, College of Medicine. Prof. Shiliang Xie from Taiwan Academia Sinica gave a welcome speech, briefly introducing the program and significance of this conference. Prof. Zhigang Tian from University of Science and Technology of China, President of Chinese Society for Immunology, introduced the prevoius five conferences and concluded that as a professional summit forum of immunology, this serial conference provides a wonderful face-to-face communicating opportunity for immunologists from Cross Straight. Prof. Tian also hopes that all meeting participants communicate extensively, discuss deeply and make achievements in the future based on the exchanges and communications of this conference. Prof. Fudong Liu, Deputy President of Taiwan Academia Sinica, and Prof. Borun Jiang, Deputy President of Affiliated Hospital, College of Medicine, Taiwan University, also attended this conference.During the conference, 24 immunologists from University of Science and Technology of China, Tsinghua University, Fudan University, Shandong University, Shanghai Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Institute of Microbiology Chinese Academy of Sciences, Shanghai Institute of Immunology, Taiwan Academia Sinica, Taiwan University, Taiwan Yang-Ming University, Taiwan Tsing Hua University, Taiwan Chang Gung University, Taiwan Chang Gung Hospital, Taipei Medical University, Far Eastern Hospital, the University of Hong Kong, and the Chinese University of Hong Kong, shared their new findings and discussed progresses in the field of immunology. More than one hundred experts, scholars and students of clinical and basic immunology attended this conference.Cross Straight Immunology Conference was founded in 2010, attributed to proposal, coordination and guidance of Prof. Xuetao Cao, Secretary-General of Chinese Society for Immunology (President at that time). The mainland side was supported by Chinese Society for Immunology, Chinese Academy of Medical Sciences, and National Natural Science Foundation of China. It is suggested that the conference should be held once a year in Cross Straight in turn. The former five conferences have been held in 2010 at Guangzhou, 2011 at Taipei, 2012 at Hefei, 2014 at Taipei, and 2015 at Jinan, respectively.

  Read More
• 

  The 4th cross straight immunology conference

  2014-05-12

  The 4th cross straight immunology conference has been held at Taiwan Yang Ming University on April 28-29, 2014. This conference was hosted by immunology research center, Taiwan Yang Ming University. Prof. Shiliang Xie from Taiwan Yang Ming University was the chairman of the conference, and Prof. Zhigang Tian from University of Science and Technology of China co-chaired the conference. 10 immunologists from Chinese Mainland, 15 immunologists from Taiwan and 3 immunologists from Hongkong were invited to give speeches at the conference. The topics of speeches were around the frontier issues of immunology research, mainly including host pathogen interaction, immunobiology and aseptic inflammation and cancer. More than 200 experts, researchers and students of clinical and basic immunology attended this meeting.Prof. Zhigang Tian made the welcome speech as the representative of Chinese Mainland. He gave high praise to this serial conference for it has kept good traditions of the last three conferences, showing the characteristics of professional symposium, and providing a face-to-face communication platform for the immunologists from Chinese Mainland, Taiwan, Hongkong and Aomen.This time, invited speakers were from University of Science and Technology of China, Tsinghua University, Shanghai Jiao Tong University, Zhejiang University, Nanjing University, Tongji University, Shandong University, Institute of Bioscience, Chinese Academy of Sciences, Taiwan Academia Sinica, Taiwan Healthy Research Institutes, Taiwan University Medical School, Taiwan Yang Ming University, Taiwan Chang Gung University, Hongkong University as well as the Chinese University of Hongkong, and they made speeches respectively.The cross straight immunology conference was first held at Guangzhou in 2010, which was initiated by Prof. Xuetao Cao, the president of Chinese Society for Immunology. Besides Chinese Society for Immunology, Chinese Academy of Medical Sciences and the Committee of National Natural Science Foundation of China are the co-contributors from the side of Chinese Mainland. According to the conference organization committee this serial conference is designed as an annual meeting: the 2nd conference has been held at Taipei in 2011, and the 3rd at Hefei in 2012.

  Read More